logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
24/09/2025
AstraZeneca: Trastuzumab deruxtecan in combination with pertuzumab receives priority review in the United States for first-line treatment of HER2-positive metastatic breast cancer patients.
Latest
2 m ago
Morgan Stanley downgraded Adobe's rating from "overweight" to "hold" and the stock fell 1.3% in pre-market trading.
2 m ago
Popular Chinese concept stocks collectively surged in pre-market trading, with Alibaba rising nearly 10% and investing 380 billion to increase their investment in AI and announcing a partnership with Nvidia to develop Physical AI. Wanguo Data rose more than 9%, JD.com rose nearly 4%, and Bilibili and Nio both rose over 2%.
2 m ago
Shenzhen Airport: Flights will resume operations starting from 8pm on September 24th.
3 m ago
Kangxin New Materials is transferring 60% equity of its subsidiary, after the transaction is completed, it will focus on its core business.
3 m ago
Jingjia Corporation provides joint liability guarantees for a comprehensive credit of 200 million yuan to a subsidiary.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.